This is a Phase 1/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of LTZ-232 in Participants With Advanced/Metastatic Colorectal Cancer and Other Solid Tumors
Sponsor: LTZ Therapeutics, Inc.
Scottsdale, AZ
13 recruiting colorectal cancer studies with a site in Scottsdale, AZ.
Sponsor: LTZ Therapeutics, Inc.
Scottsdale, AZ
Sponsor: Pfizer
Chandler, AZ · Gilbert, AZ · +251 more sites
Sponsor: Parabilis Medicines, Inc.
Phoenix, AZ · Scottsdale, AZ · Tucson, AZ · +28 more sites
Sponsor: Eli Lilly and Company
Scottsdale, AZ · +10 more sites
Sponsor: Avacta Life Sciences Ltd
Scottsdale, AZ · +6 more sites
Sponsor: Revolution Medicines, Inc.
Chandler, AZ · Phoenix, AZ · Scottsdale, AZ · +29 more sites
Sponsor: VM Discovery, Inc.
Scottsdale, AZ
Sponsor: AstraZeneca
Scottsdale, AZ · +13 more sites
Sponsor: Artios Pharma Ltd
Scottsdale, AZ · +40 more sites
Sponsor: Recursion Pharmaceuticals Inc.
Scottsdale, AZ · Tucson, AZ · +15 more sites
Sponsor: Guerbet
Scottsdale, AZ · +15 more sites
Sponsor: GI Innovation, Inc.
Scottsdale, AZ · +4 more sites
Sponsor: BioEclipse Therapeutics
Scottsdale, AZ · +2 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.